Pax Labs Inc. valued at $5 billion
Pax Labs Inc, a San Fransisco-based start-up that produces vaporizers, was recently valued at $5 billion. according to Bloomberg. Discreet, portable and high-tech, Pax vaporizers are a huge success in the United States, as cannabis consumption changes.
Frequently dubbed the 'iPhone of cannabis», the Pax resembles a high-tech USB key. Its discretion makes it an asset of choice for consumers on the move, who can modify its settings (temperature, light...) via a smartphone app.

A controversial cousin
The vape is based on the same operating principle as the Juul, a vaporizer for concentrated nicotine. And with good reason: they were both created by James Monsees and Adam Bowen.
The original company was split into two separate entities last year, Juul Labs and Pax Labs, surely to avoid the Juul controversy rubbing off on Pax, but also because the two products are subject to different regulatory frameworks.
Juul has been the subject of controversy, as it has become widely popular among teenagers. Although e-cigarette consumption is less toxic than traditional cigarettes, the nicotine concentration and fad surrounding vaping are causing addiction problems among teenagers. To combat this «epidemic», the FDA has issued an ultimatum to the producers of the most popular devices to prove that they can keep their product out of the hands of minors. Today, an investigation is underway to determine whether Juul Labs marketed its product for teenage consumption.
Vaporizers are sold empty, without cartridges. The cartridges are sold empty to producers who fill and distribute them (often in the same places as the vaporizer), a way of protecting themselves from consumer use, even though the products are more or less clearly intended for the consumption of concentrates, whether nicotine for the Juul or cannabis for certain versions of the Pax (the Pax 3 and the Pax Era).
The company's latest fund-raising totaled $20 million-a round «deliberately small» according to Pax's new CEO, Bharat Vasan, and reduced to investors already involved in the company. Although legally separate, the two companies also share the same investor base.
-
Business6 days ago
The legal cannabis market in New York exceeds 4 billion $ in revenue
-
Cannabis in France2 weeks ago
Which countries legalized medical cannabis before France?
-
Business2 weeks ago
South Korea is preparing to begin local production of medical cannabis to meet rising demand
-
Cannabis in the Netherlands4 weeks ago
One year after the launch of the Dutch cannabis experiment, the first trends are emerging
-
Cannabis in Thailand2 weeks ago
From the boom in dispensaries to a purely medical approach: Thailand is revising its cannabis policy
-
Cannabis in France4 weeks ago
French medical cannabis remains stalled at the Ministry of Health
-
Cannabis in Argentina3 weeks ago
Argentina Opens Its Market to Hemp Flowers Containing 1% of THC
-
Cannabis and driving2 weeks ago
Medical Cannabis and Driving: New South Wales Ends Automatic Penalties for THC


You must be logged in to post a comment Login